Login to Your Account



POTENTIAL LAUNCH IN MAY 2015

Sandoz International's Zarxio on path to become first official U.S. biosimilar

By Mari Serebrov
Washington Editor

Friday, July 25, 2014
The FDA is a stone's throw away from approving its first official biosimilar – a filgrastim follow-on developed by Sandoz International GmbH.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription